Displaying drugs 2501 - 2525 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Teriflunomide | 270.2073 C12H9F3N2O2 |  | A pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis. | Selective Immunosuppressants |
| Terizidone | 302.29 C14H14N4O4 |  | Terizidone has been used in trials studying the treatment of Tuberculosis, HIV Infections, Multidrug Resistant Tuberculosis, and Extensively-drug Resistant Tuberculosis. | Antiinfectives for Systemic Use / Antimycobacterials / Drugs for Treatment of Tuberculosis / Oxazoles |
| Terpin hydrate | 190.283 C10H22O3 |  | An expectorant used to treat bronchitis, pneumonia, bronchiectasis, COPD, and infectious or inflammatory diseases of the upper respiratory tract. | Expectorants |
| Testolactone | 300.3921 C19H24O3 |  | A medication used to treat advanced breast cancer. | Androstadienes / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Homosteroids |
| Testosterone | 288.4244 C19H28O2 |  | A hormone used to treat hypogonadism, breast carcinoma in women, or the vasomotor symptoms of menopause. | 3-Oxoandrosten (4) Derivatives / Androgens and Estrogens |
| Testosterone cypionate | 412.614 C27H40O3 |  | An androgen used to treat low or absent testosterone. | Anabolic Agents / Androgens / Delayed-Action Preparations |
| Testosterone enantate benzilic acid hydrazone | 624.866 C40H52N2O4 |  | Not Annotated | Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Steroids / Testosterone and derivatives / Testosterone Congeners |
| Testosterone enanthate | 400.594 C26H40O3 |  | An androgen used to treat low or absent testosterone. | Androgens |
| Testosterone propionate | 344.4877 C22H32O3 |  | A slow-release anabolic steroid no longer used commonly for the treatment of androgen deficiency or promotion of anabolic effects on muscles. | Androgens / Testosterone Congeners |
| Testosterone undecanoate | 456.711 C30H48O3 |  | An androgen indicated for testosterone replacement therapy in adult males with primary hypogonadism and hypogonadotropic hypogonadism. | Androgens |
| Tetrabenazine | 317.4226 C19H27NO3 |  | A vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington's Disease. | Quinolizines / Vesicular Monoamine Transporter 2 Inhibitor |
| Tetracaine | 264.369 C15H24N2O2 |  | A local anaesthetic agent used to induce local analgesia in the eyes and skin during medical procedures. | Anesthetics for Topical Use / Esters of Aminobenzoic Acid |
| Tetrachlorodecaoxide | 319.821 Cl4H2O11 |  | Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, cancer/tumors (unspecified), HIV infection, and inflammatory disorders (unspecified). | Radiation-Protective Agents |
| Tetracosactide | 2933.49 C136H210N40O31S |  | A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency. | Adrenocorticotropic Hormone / Hormones |
| Tetracycline | 444.4346 C22H24N2O8 |  | An antibiotic used to treat a wide variety of susceptible infections. | Antiinfectives and Antiseptics for Local Oral Treatment |
| Tetracycline phosphate complex | 4821.729 C198H225N18NaO102P10 |  | Not Annotated | Anti-Bacterial Agents |
| Tetradecyl hydrogen sulfate (ester) | 294.45 C14H30O4S |  | An anionic surfactant used to treat small uncomplicated varicose veins. | Drugs that are Mainly Renally Excreted |
| Tetraferric tricitrate decahydrate | 967.803 C18H32Fe4O31 |  | A phosphate binder used to control serum phosphorus levels or as an iron supplement. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia |
| Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate | 602.99 C24H44BCuF4N4O4 |  | Tetrakis (2-methoxyisobutylisocyanide) copper (I) tetrafluoroborate is a component of Cardiolite, a technetium Tc99m-based imaging agent used for assessing myocardial perfusion. | Not Annotated |
| Tetramethylthiuram monosulfide | 208.36 C6H12N2S3 |  | Not Annotated | Standardized Chemical Allergen |
| Tetrofosmin | 382.462 C18H40O4P2 |  | A diphosphine complexed with technetium 99 used for imaging to determine myocardial ischemia, infarcted myocardium, and assessment of left ventricular function. | Radioactive Diagnostic Agent |
| Tetryzoline | 200.285 C13H16N2 |  | An alpha-adrenergic agonist used in the temporary symptomatic relief of discomfort and redness of the eyes due to minor irritations, as well as alleviate nasal congestion. | Sympathomimetics Used as Decongestants / Sympathomimetics, Plain |
| Tezacaftor | 520.505 C26H27F3N2O6 |  | A medication used to treat homozygous or heterozygous F508del mutation cystic fibrosis. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inducers / Cytochrome P-450 CYP3A5 Inducers (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dioxoles / Heterocyclic Compounds, Fused-Ring / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
| Thalidomide | 258.2295 C13H10N2O4 |  | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. | Angiogenesis Inhibitors / Drugs causing inadvertant photosensitivity / Leprostatic Agents / Phthalimides / Teratogens |
| Thallous chloride | 239.836 ClTl |  | A diagnostic radiopharmaceutical for myocardial perfusion testing and tests of parathyroid function. | Radioactive Diagnostic Agent |
Displaying drugs 2501 - 2525 of 2779 in total